Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-15196 · Session 2

Whether NHS Quality Improvement Scotland will review drug prescribing guidance in relation to the treatment of Alhzheimer's disease.

Answered Asked by Irene Oldfather Lab Lodged 10 Mar 2005

The question

To ask the Scottish Executive whether NHS Quality Improvement Scotland will review drug prescribing guidance in relation to the treatment of Alhzheimer's disease.

The answer

Answered by Andy Kerr on 17 Mar 2005 · 7 days after it was lodged, on time

The National Institute for ClinicalExcellence (NICE) has published an Appraisal Consultation Document entitled Alzheimer'sdisease
- donepezil, rivastigmine, galantamine and memantine. The consultation is openuntil 22 March 2005 and can be accessed at:
http://www.nice.org.uk/page.aspx?o=245912.
The consultation document doesnot constitute the Institute's formal guidance on these drugs and the recommendationmade is preliminary and may change after the consultation. A final recommendationwill be made later in the year. At that point, NHS Quality Improvement Scotlandwill provide advice on how relevant the guidance from NICE on these drugs is forNHSScotland.

In the Official Report

No contribution in the Official Report cites S2W-15196 by reference.